Researcher profile

Andres Acosta, MD, PhD

He works on GLP-1 response in older adults specifically, which is the population the pivotal trials mostly excluded and the population reading about GLP-1 for longevity. His research sorts obesity into phenotypes, such as a hungry brain or a hungry gut, to predict which patients respond to which treatment.

Role
Gastroenterologist and obesity specialist
Affiliation
Mayo Clinic
Topics
GLP-1 · Muscle loss · Older adults
Their work

Why we quote Acosta

He works on GLP-1 response in older adults specifically, which is the population the pivotal trials mostly excluded and the population reading about GLP-1 for longevity. His research sorts obesity into phenotypes, such as a hungry brain or a hungry gut, to predict which patients respond to which treatment.

Andres Acosta, MD, PhD is one of the researchers quoted here; the others quoted alongside Andres are listed with the same disclosures.

Where they stand, and who pays

Academic clinician and co-founder of Phenomix Sciences, a company that sells an obesity phenotype test; has had industry research relationships common in this field.

Stating this next to the quote rather than at the bottom of a disclosures page is the whole point. A concession made against a commercial interest is stronger evidence than a neutral summary; a claim made in line with one is weaker. You cannot weigh either without knowing which you are reading.

Every line below is transcribed from a public recording and linked back to it. Nothing here is paraphrased, and Acosta has no relationship with this site.

Everything we quote them saying

The one line, verbatim, in the order they appear in the site's citation index. Each one links to the recording and to the page it is used on.

For every two parts of fat that you lose, you lose one of muscle.

Andres Acosta, MD, PhD(profile) Gastroenterologist and obesity specialist, Mayo Clinic Mayo Clinic Aging Forward podcast, 2026

Used on GLP-1 Longevity: The Best Hard-Outcome Data in the Field

Pages this research informs

Each page below cites this researcher directly, so you can see the claim a quote supports in its full context.

The standing disclaimer

Andres Acosta, MD, PhD has no relationship with Rapamycin.store and does not endorse anything on it.

  • They have not reviewed this site or any page that quotes them.
  • Quotes are used under fair dealing for criticism and review, each linked to its public recording so you can hear the full context.
  • If a quote here misrepresents what was said, tell us and we will correct it. That correction goes to the front of the queue.

Researchers who want to set out a position in their own words, rather than be quoted, can write for the desk directly.

References

3 sources, all link-checked; oldest check

  1. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. International Committee of Medical Journal Editors, updated 2025.The conflict-of-interest and authorship conventions this desk follows for a lay publication.Verified Sep 14, 2026
  2. PubMed. US National Library of Medicine, National Institutes of Health.The index every citation on this site is checked against before publication.Verified Sep 14, 2026
  3. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Guyatt GH et al. BMJ 2008;336:924.The framework behind the strong / mixed / limited evidence grades used across this site.Verified Sep 14, 2026

Every link above is re-requested on a schedule by an automated checker; the date shown is when it last answered. Publishers that block automated requests are marked as such rather than reported broken. Our editorial standards explain how a source gets cited here in the first place.

Filed by the Rapamycin.store evidence desk. Each source is re-checked when the page is reviewed.

Own a longevity or health brand?

Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.